You are here

Brukinsa

BeiGene fleshes out global ambition as Brukinsa surpasses AstraZeneca's Calquence in quarterly sales

Fierce Pharma

Fri, 02/28/25 - 11:03 am

[podcast]Brukinsa approval raises BeiGene’s hematology profile

Medical Marketing and Media

Wed, 03/20/24 - 09:38 pm

FDA approves expanded use of BeiGene's blood cancer drug

Reuters

Thu, 03/7/24 - 05:30 pm

AbbVie sues BeiGene over brand-new Imbruvica patent as blood cancer rivalry heats up

Fierce Pharma

Fri, 06/16/23 - 09:44 am

BeiGene doubles sales as Brukinsa, tislelizumab gear up for key launches

Fierce Pharma

Mon, 02/27/23 - 07:06 pm

BeiGene's Brukinsa wins CLL approval after topping Imbruvica in head-to-head trial

Endpoints

Thu, 01/19/23 - 08:55 pm

ASH 2022 – pirtobrutinib leads the post-Imbruvica charge

EP Vantage

Wed, 12/14/22 - 10:18 am

Nurix Therapeutics

BeiGene heaps more pressure on AbbVie, J&J with new Brukinsa head-to-head win over Imbruvica

Fierce Pharma

Wed, 10/12/22 - 11:00 am

ASH: Chasing AbbVie and J&J's Imbruvica, BeiGene's Brukinsa fleshes out competitive leukemia data again

Fierce Biotech

Thu, 11/4/21 - 10:27 am

clinical trials

FDA grants BeiGene's Brukinsa accelerated approval in marginal zone lymphoma

Seeking Alpha

Wed, 09/15/21 - 11:00 am

accelerated approvals

marginal zone lymphoma

FDA approves BeiGene's Brukinsa in rare blood cancer amid company's US expansion plans

Endpoints

Thu, 09/2/21 - 10:29 am

BeiGene tees up 3-way leukemia competition against J&J-AbbVie, AstraZeneca with Brukinsa win

Fierce Pharma

Mon, 08/2/21 - 10:57 am

small lymphocytic lymphoma

clinical trials

ASH: AstraZeneca's Calquence, BeiGene's Brukinsa turn heads with new data, putting Imbruvica on notice

Fierce Pharma

Sun, 12/6/20 - 07:15 pm

Important catalysts approach for smaller biotechs

EP Vantage

Wed, 06/24/20 - 10:35 am

Turning Point Therapeutics

Intra-Cellular Therapies

clinical trials

3 Blockbuster Cancer Drug Launches to Watch in 2020

Motley Fool

Thu, 01/2/20 - 11:57 pm

Seattle Genetics

5 New Drug Approvals the FDA Gave Top Priority

Motley Fool

Sat, 11/30/19 - 11:22 pm

Global Blood Therapeutics

Vertex Pharmaceuticals

FDA Approves 5 New Costly Drugs Well Ahead of PDUFA Dates

RAPS.org

Wed, 11/27/19 - 12:39 pm

Vertex Pharmaceuticals

Global Blood Therapeutics

China's BeiGene gets FDA approval for drug to treat rare form of lymphoma

Yahoo/Reuters

Thu, 11/14/19 - 07:27 pm

mantle cell lymphoma